|
1
|
Pernar CH, Ebot EM, Wilson KM and Mucci
LA: The epidemiology of prostate cancer. Cold Spring Harb Perspect
Med. 8(a030361)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Catalona WJ: Prostate cancer screening.
Med Clin North Am. 102:199–214. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Boyle HJ, Alibhai S, Decoster L,
Efstathiou E, Fizazi K, Mottet N, Oudard S, Payne H, Prentice M,
Puts M, et al: Updated recommendations of the international society
of geriatric oncology on prostate cancer management in older
patients. Eur J Cancer. 116:116–136. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Swami U, McFarland TR, Nussenzveig R and
Agarwal N: Advanced prostate cancer: Treatment advances and future
directions. Trends Cancer. 6:702–715. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Charar C and Gruenbaum Y: Lamins and
metabolism. Clin Sci (Lond). 131:105–111. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qin H, Lu Y, Du L, Shi J, Yin H, Jiang B,
Chen W, Diao W, Ding M, Cao W, et al: Pan-cancer analysis
identifies LMNB1 as a target to redress Th1/Th2 imbalance and
enhance PARP inhibitor response in human cancers. Cancer Cell Int.
22(101)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Golson ML and Kaestner KH: Fox
transcription factors: From development to disease. Development.
143:4558–4570. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Koga M, Matsuda M, Kawamura T, Sogo T,
Shigeno A, Nishida E and Ebisuya M: Foxd1 is a mediator and
indicator of the cell reprogramming process. Nat Commun.
5(3197)2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen C, Xu ZQ, Zong YP, Ou BC, Shen XH,
Feng H, Zheng MH, Zhao JK and Lu AG: CXCL5 induces tumor
angiogenesis via enhancing the expression of FOXD1 mediated by the
AKT/NF-κB pathway in colorectal cancer. Cell Death Dis.
10(178)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gao YF, Liu JY, Mao XY, He ZW, Zhu T, Wang
ZB, Li X, Yin JY, Zhang W, Zhou HH and Liu ZQ: LncRNA FOXD1-AS1
acts as a potential oncogenic biomarker in glioma. CNS Neurosci
Ther. 26:66–75. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li D, Fan S, Yu F, Zhu X, Song Y, Ye M,
Fan L and Lv Z: FOXD1 promotes cell growth and metastasis by
activation of vimentin in NSCLC. Cell Physiol Biochem.
51:2716–2731. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Huang J, Liang B and Wang T: FOXD1
expression in head and neck squamous carcinoma: A study based on
TCGA, GEO and meta-analysis. Biosci Rep.
41(BSR20210158)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ren D, Lu J, Han X, Xiong W, Jiang H, Wei
Y and Wang Y: LINC00641 contributes to nasopharyngeal carcinoma
cell malignancy through FOXD1 upregulation at the
post-transcriptional level. Biochem Cell Biol. 99:750–758.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fan L, Wang J, Deng P, Wang Y, Zhang A,
Yang M and Zeng G: Foxhead box D1 promotes the partial
epithelial-to-mesenchymal transition of laryngeal squamous cell
carcinoma cells via transcriptionally activating the expression of
zinc finger protein 532. Bioengineered. 13:3057–3069.
2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jin Y, Liang Z and Lou H: The emerging
roles of fox family transcription factors in chromosome
replication, organization, and genome stability. Cells.
9(258)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347(1260419)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Quintero-Ronderos P and Laissue P: The
multisystemic functions of FOXD1 in development and disease. J Mol
Med (Berl). 96:725–739. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun Q, Novak D, Hüser L, Poelchen J, Wu H,
Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, et al:
FOXD1 promotes dedifferentiation and targeted therapy resistance in
melanoma by regulating the expression of connective tissue growth
factor. Int J Cancer. 149:657–674. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zong Y, Miao Y, Li W, Zheng M, Xu Z, Gao
H, Feng W, Xu Z, Zhao J, Shen L and Lu A: Combination of FOXD1 and
Plk2: A novel biomarker for predicting unfavourable prognosis of
colorectal cancer. J Cell Mol Med. 26:3471–3482. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li Z, Yan T, Wu X, Zhang W, Li J, Wang L
and Yang J: Increased expression of FOXD1 is associated with
cervical node metastasis and unfavorable prognosis in oral squamous
cell carcinoma. J Oral Pathol Med. 49:1030–1036. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cai K, Chen S, Zhu C, Li L, Yu C, He Z and
Sun C: FOXD1 facilitates pancreatic cancer cell proliferation,
invasion, and metastasis by regulating GLUT1-mediated aerobic
glycolysis. Cell Death Dis. 13(765)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Donmez C and Konac E: Silencing effects of
FOXD1 inhibit metastatic potentials of the PCa via
N-cadherin-Wnt/β-catenin crosstalk. Gene.
836(146680)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li J, Sun Z, Cui Y, Qin L, Wu F, Li Y, Du
N and Li X: Knockdown of LMNB1 inhibits the proliferation of lung
adenocarcinoma cells by inducing DNA damage and cell senescence.
Front Oncol. 12(913740)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saed L, Jeleń A, Mirowski M and
Sałagacka-Kubiak A: Prognostic significance of HMGA1 expression in
lung cancer based on bioinformatics analysis. Int J Mol Sci.
23(6933)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Evangelisti C, Rusciano I, Mongiorgi S,
Ramazzotti G, Lattanzi G, Manzoli L, Cocco L and Ratti S: The wide
and growing range of lamin B-related diseases: From laminopathies
to cancer. Cell Mol Life Sci. 79(126)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Luo F, Han J, Chen Y, Yang K, Zhang Z and
Li J: Lamin B1 promotes tumor progression and metastasis in primary
prostate cancer patients. Future Oncol. 17:663–673. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hua Y, He Z and Zhang X: A pan-cancer
analysis based on weighted gene co-expression network analysis
identifies the biomarker utility of lamin B1 in human tumors.
Cancer Biomark. 34:23–39. 2022.PubMed/NCBI View Article : Google Scholar
|
